Efficacy and safety of taspoglutide in patients with type 2 diabetes inadequately controlled with metformin plus pioglitazone over 24 weeks: T-Emerge 3 trial (Q43426726)
Jump to navigation
Jump to search
scientific article published on 26 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of taspoglutide in patients with type 2 diabetes inadequately controlled with metformin plus pioglitazone over 24 weeks: T-Emerge 3 trial |
scientific article published on 26 April 2012 |
Statements
1 reference
Efficacy and safety of taspoglutide in patients with type 2 diabetes inadequately controlled with metformin plus pioglitazone over 24 weeks: T-Emerge 3 trial (English)
1 reference
Robert R Henry
1 reference
Sunder Mudaliar
1 reference
Linda Kanitra
1 reference
Michael Woloschak
1 reference
Raffaella Balena
1 reference
T-Emerge 3 Study Group
1 reference
26 April 2012
1 reference
1 reference
Identifiers
1 reference